BURLINGTON, Mass.--(BUSINESS WIRE)--In honor of the first ever HAE Day upcoming on May 16, 2012, Dyax Corp. (NASDAQ: DYAX), the manufacturer of KALBITOR® (ecallantide) for the treatment of acute attacks of HAE in patients 16 years of age and older, announced a donation of $17,700 to the United States Hereditary Angioedema Association (HAEA), the largest Hereditary Angioedema (HAE) patient group in the world. The donation results from fundraising activities held at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting in Orlando, FL, where Dyax dedicated a significant portion of their booth to recognizing HAE Global Awareness Day on May 16, 2012 and raising funds to support the HAEA.
